Showing results (101-110 of 231) with videos related to
Sort By:
Pageof 24
Journal of AIDS & Clinical Research|October 25, 2016
The Art of HIV Elimination: Past and Present ScienceCollins C Iwuji, Nuala McGrath, Tulio de Oliveira, et al.Plos One|February 7, 2015
A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individualsGraeme J Moyle, Chloe Orkin, Martin Fisher, et al.Antiviral Therapy|November 13, 2004
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenzFrank van Leth, Brian Conway, Hector Laplumé, et al.Proceedings of the National Academy of Sciences of the United States of America|January 10, 2009
Active site dynamics in the zinc-dependent medium chain alcohol dehydrogenase superfamilyPatrick J Baker, K Linda Britton, Martin Fisher, et al.AIDS Care|April 24, 2012
What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factorsRichard Harding, Claudine Clucas, Fiona C Lampe, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trialWilliam Burman, Birgit Grund, Jacqueline Neuhaus, et al.AIDS (London, England)|September 16, 2015
Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patientsLisa Hamzah, Amanda Samarawickrama, Lucy Campbell, et al.The Journal of Antimicrobial Chemotherapy|December 21, 2004
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study)Chloe Orkin, Justin Stebbing, Mark Nelson, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and preliminary X-ray analysis of binary and ternary complexes of Haloferax mediterranei glucose dehydrogenaseJulia Esclapez, K Linda Britton, Patrick J Baker, et al.AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.Pageof 24